Saygın Avşar Tuba, Jackson Louise, Barton Pelham, Jones Matthew, McLeod Hugh
Department of Applied Health Research, University College London, London, UK.
Health Economics Unit, University of Birmingham, Birmingham, UK.
Addiction. 2022 Oct;117(10):2707-2719. doi: 10.1111/add.15955. Epub 2022 Jun 13.
Previous economic evaluations of smoking cessation interventions for pregnant women are limited to single components, which do not in isolation offer sufficient potential impact to address smoking cessation targets. To inform the development of more appropriate complex interventions, we (1) describe the development of the Economics of Smoking in Pregnancy: Household (ESIP.H) model for estimating the life-time cost-effectiveness of smoking cessation interventions aimed at pregnant women and (2) use a hypothetical case study to demonstrate how ESIP.H can be used to identify the characteristics of optimum smoking cessation interventions.
The hypothetical intervention was based on current evidence relating to component elements, including financial incentives, partner smoking, intensive behaviour change support, cigarettes consumption and duration of support to 12 months post-partum. ESIP.H was developed to assess the life-time health and cost impacts of multi-component interventions compared with standard National Health Service (NHS) care in England. ESIP.H considers cigarette consumption, partner smoking and some health conditions (e.g. obesity) that were not included in previous models. The Markov model's parameters were estimated based on published literature, expert judgement and evidence-based assumptions. The hypothetical intervention was evaluated from an NHS perspective.
The hypothetical intervention was associated with an incremental gain in quitters (mother and partner) at 12 months postpartum of 249 [95% confidence interval (CI) = 195-304] per 1000 pregnant smokers. Over the long-term, it had an incremental negative cost of £193 (CI = -£779 to 344) and it improved health, with a 0.50 (CI = 0.36-0.69) increase in quality-adjusted life years (QALYs) for mothers, partners and offspring, with a 100% probability of being cost-effective.
The Economics of Smoking in Pregnancy: Household model for estimating cost-effectiveness of smoking cessation interventions aimed at pregnant women found that a hypothetical smoking cessation intervention would greatly extend reach, reduce smoking and be cost-effective.
先前对孕妇戒烟干预措施的经济评估仅限于单一组成部分,这些单一组成部分单独来看,对实现戒烟目标的潜在影响不足。为了为开发更合适的综合干预措施提供信息,我们(1)描述了孕期吸烟经济学:家庭(ESIP.H)模型的开发过程,该模型用于评估针对孕妇的戒烟干预措施的终生成本效益;(2)通过一个假设案例研究,展示如何使用ESIP.H来确定最佳戒烟干预措施的特征。
假设干预措施基于与组成要素相关的现有证据,包括经济激励、伴侣吸烟、强化行为改变支持、香烟消费以及产后12个月的支持时长。开发ESIP.H模型是为了评估多组成部分干预措施与英国标准国民保健服务(NHS)护理相比,对终生健康和成本的影响。ESIP.H模型考虑了香烟消费、伴侣吸烟以及一些先前模型未纳入的健康状况(如肥胖)。马尔可夫模型的参数基于已发表的文献、专家判断和循证假设进行估计。从NHS的角度对假设干预措施进行评估。
该假设干预措施使产后12个月时每1000名怀孕吸烟者中成功戒烟者(母亲和伴侣)的数量增加了249人[95%置信区间(CI)=195 - 304]。从长期来看,其增量成本为负193英镑(CI = -779至344英镑),并且改善了健康状况,母亲、伴侣和后代的质量调整生命年(QALYs)增加了0.50(CI = 0.36 - 0.69),具有100%的成本效益概率。
孕期吸烟经济学:家庭模型用于评估针对孕妇的戒烟干预措施的成本效益,结果发现一项假设的戒烟干预措施将极大地扩大覆盖面、减少吸烟且具有成本效益。